origin of glp 1 drugs Frontiers Mechanism of action of GLP-1

Archana Batra, a dietitian and certified diabetes educator

In preclinical studies, BPC-157 demonstrated an exceptionally wide therapeutic window with no observed toxicity even at high doses. Sikiric et al., Current Pharmaceutical Design Long-Term Safety As of now, long-term human safety data is lacking

Skin reactions, Gastrointestinal problems, and Drug interactions

Complementary compounds: Epitalon is often discussed alongside GHK-Cu for tissue-level anti-aging support, or mitochondrial peptides like MOTS-c for metabolic function

It is possible that this increase in nitrate/nitrite may have implications related to enhanced blood flow during acute bouts of exercise

32 SharmaG.ShinE